Begin main content

Influential health guidelines updated to keep pace with advancing economic methods

March 28, 2017
Ottawa - It’s a document you’d be forgiven for not knowing exists, but for those in the know, today’s arrival of CADTH’s fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada is highly anticipated in Canada and abroad. This set of guidelines from CADTH, which stands for the Canadian Agency for Drugs and Tech...

New Sessions Added to 2017 CADTH Symposium

March 27, 2017
The 2017 CADTH Symposium program has been updated with new sessions, including: The Role of Artificial Intelligence In Canada’s Health Care Sector Incorporating Indigenous Perspectives into Health Technology Management INESSS: Improving the Value of Health Care by Combining Knowledge-Based Evidence With Real-World Experience New Innovations in ...

Special Event: New Guidelines for the Economic Evaluation of Health Technologies: Canada

March 21, 2017
Join us in person or online on Tuesday, March 28, 2017 as we release the fourth edition of the Guidelines for the Economic Evaluation of Health Technologies: Canada. This release marks the first update to the Guidelines since the third edition was published in 2006. The Guidelines are intended to help produce credible and standardized economic i...

Call for Patient Input: Dysport Therapeutic

March 17, 2017
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website. Dysport Therapeutic Brand name Generic name Ma...